INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 458m ago
HOUSE PTR58m ago
SEC 13F58m ago
ROBINHOOD CHAIN58m ago
Public company

WHWKWhitehawk Therapeutics, Inc.

CIK 0001422142

EDGAR filingsOpen in network
Disclosed transactions31
Buys / sells0 / 10
Max Insider Score35
Connections9with evidence

WHWK · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
DD
Dornan DavidChief Scientific Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
85.9K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Dornan DavidChief Scientific Officer · Sep 15, 2026
  • ← Insider ofevidence
    Giacobello Scott M.CHIEF FINANCIAL OFFICER · Sep 15, 2026
  • ← Insider ofevidence
    Iyengar Vijay KDirector · Sep 11, 2026
5
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A
—
91.6K sh
Sep 15, 2026
Sep 15, 2026
traded Sep 15, 2026
+0d
SEC FORM 4

Evidence

5
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
91.6K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
GM
Giacobello Scott M.CHIEF FINANCIAL OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
118.5K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
DM
Dugan MargaretChief Medical Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
81.3K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
GM
Giacobello Scott M.CHIEF FINANCIAL OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
118.5K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
DM
Dugan MargaretChief Medical Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
81.3K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

2
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
194.0K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
DD
Dornan DavidChief Scientific Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
85.9K sh
Sep 15, 2026Sep 15, 2026
traded Sep 15, 2026
+0dSEC FORM 4

Evidence

9
IK
Iyengar Vijay KDirector
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
76.1K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC FORM 4

Evidence

9
ZB
Zhao BaitengDirector
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
38.0K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC FORM 4

Evidence

9
DN
Desai NeilDirector
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
38.0K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC FORM 4

Evidence

9
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A$200K
51.0K sh
May 14, 2026May 18, 2026
traded May 14, 2026
+4dSEC FORM 4

Evidence

32
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$337K
92.5K sh
Apr 14, 2026Apr 15, 2026
traded Apr 14, 2026
+1dSEC FORM 4

Evidence

29
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$91K
26.4K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

33
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$179K
50.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

22
BB
Ball BryanSee remarks
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$23K
6,596 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC FORM 4

Evidence

22
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$49K
14.5K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

32
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$323K
94.1K sh
Apr 7, 2026Apr 8, 2026
traded Apr 7, 2026
+1dSEC FORM 4

Evidence

32
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$359K
102.4K sh
Apr 6, 2026Apr 8, 2026
traded Apr 6, 2026
+2dSEC FORM 4

Evidence

29
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$217K
63.9K sh
Apr 8, 2026Apr 8, 2026
traded Apr 8, 2026
+0dSEC FORM 4

Evidence

25
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$93K
26.9K sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC FORM 4

Evidence

17
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
775.8K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

5
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
775.8K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

5
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
831.1K sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC FORM 4

Evidence

31
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
16.3K sh
Mar 1, 2026Mar 10, 2026
traded Mar 1, 2026
+9dSEC FORM 4

Evidence

35
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Open-market sale
SELL$17K
5,100 sh
Mar 2, 2026Mar 10, 2026
traded Mar 2, 2026
+8dSEC FORM 4

Evidence

27
LJ
Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER
WHWKWhitehawk Therapeutics, Inc.
Option exercise
M—
16.3K sh
Mar 1, 2026Mar 10, 2026
traded Mar 1, 2026
+9dSEC FORM 4

Evidence

9
DM
Dugan MargaretChief Medical Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
55.3K sh
Dec 1, 2025Dec 2, 2025
traded Dec 1, 2025
+1dSEC FORM 4

Evidence

9
DM
Dugan MargaretChief Medical Officer
WHWKWhitehawk Therapeutics, Inc.
Grant or award
A—
650.0K sh
Dec 1, 2025Dec 2, 2025
traded Dec 1, 2025
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Zhao BaitengDirector · Jun 15, 2026
  • ← Insider ofevidence
    Desai NeilDirector · Jun 15, 2026
  • ← Insider ofevidence
    Ball BryanSee remarks · Apr 13, 2026
  • ← Insider ofevidence
    Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER · Mar 10, 2026
  • ← Insider ofevidence
    Dugan MargaretChief Medical Officer · Dec 2, 2025